Results 61 to 70 of about 410,667 (361)

Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report [PDF]

open access: yes, 2016
Background Ozurdex is a 700 mcg dexamethasone intravitreal implant, approved for the management of macular edema secondary to retinal vein occlusion, and other related pathoglogiesAnterior chamber dislocation of Ozurdex represents an uncommon ...
AGOSTINELLI, Enzo   +6 more
core   +1 more source

Macular Edema in Uveitis

open access: yesFolia Medica, 2012
ABSTRACT In the present study we have made a review of the relevant literature on pathogenesis and modern diagnostic methods for macular edema (ME) in uveitis. Macular edema is a typical non-specific complication of uveitis, one of the common causes of visual impairment. ME can be found in all types of uveitis. In 85%
Vesela T. Mitkova-Hristova   +1 more
openaire   +3 more sources

Improvement of pseudophakic cystoid macular edema with subconjunctival injections of interferon α2b:a case report

open access: yesAmerican Journal of Ophthalmology Case Reports, 2022
Purpose: To report a patient with resistant cystoid macular edema after an uneventful phacoemulsification cataract surgery who responded to subconjunctival interferon α2b injections.
Hossein Aghaei   +2 more
doaj  

The Role of Steroids in the Management of Diabetic Macular Edema

open access: yesOphthalmic Research, 2019
Inflammation is substantially contributing to the development and worsening of diabetic retinopathy in general and diabetic macular edema (DME) in particular, which provides the rationale to treat DME with corticosteroids. While anti-vascular endothelial
Dinah Zur   +2 more
semanticscholar   +1 more source

Ophthalmic imaging in diabetic retinopathy: A review

open access: yesClinical &Experimental Ophthalmology, Volume 50, Issue 9, Page 1082-1096, December 2022., 2022
Abstract Retinal imaging has been a key tool in the diagnosis, evaluation, management and documentation of diabetic retinopathy (DR) and diabetic macular oedema (DMO) for many decades. Imaging technologies have rapidly evolved over the last few decades, yielding images with higher resolution and contrast with less time, effort and invasiveness.
Onnisa Nanegrungsunk   +2 more
wiley   +1 more source

Comparison of Intravitreal Bevacizumab versus Triamcinolone for the Treatment of Diffuse Diabetic Macular Edema [PDF]

open access: yes, 2010
Background: Our purpose was to compare the effect of triamcinolone and bevacizumab (Avastin) on the retinal thickness and functional outcome in patients with diabetic macular edema. Methods and Materials: A collective of 32 patients, who had been treated
Al Saeidi, Rashid   +6 more
core   +1 more source

Association Between Change in Visual Acuity and Change in Central Subfield Thickness During Treatment of Diabetic Macular Edema in Participants Randomized to Aflibercept, Bevacizumab, or Ranibizumab: A Post Hoc Analysis of the Protocol T Randomized Clinical Trial.

open access: yesJAMA ophthalmology, 2019
Importance The determination of optical coherence tomography (OCT) central subfield thickness (CST) is an objective measure, and visual acuity (VA) is a subjective measure.
N. Bressler   +8 more
semanticscholar   +1 more source

One day wonder: Fast resolution of macular edema following intravitreal ranibizumab in retinal venous occlusions

open access: yesIndian Journal of Ophthalmology, 2013
Macular edema is a significant cause of vision loss in patients with central retinal vein occlusions and branch retinal vein occlusions. Vascular endothelial growth factor (VEGF) appears to be a key factor in the pathogenesis of this disease.
Lalit Verma   +3 more
doaj   +1 more source

Effect of Adding Oral Calcium Dobesilate to Laser Photocoagulation on the Macular Thickness in Patients with Diabetic Macular Edema: A Randomized Clinical Trial [PDF]

open access: yesAdvanced Pharmaceutical Bulletin, 2014
Purpose: To evaluate the effect of oral calcium dobesilate (Doxium) on macular thickness in clinically significant macular edema (CSME). Methods: Overall, 71 eyes of 40 patients with non-proliferative diabetic retinopathy and clinically significant ...
Mostafa Feghhi   +3 more
doaj   +1 more source

Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion

open access: yesJAMA ophthalmology, 2019
This randomized clinical trial compares the clinical effectiveness of intravitreal therapy with ranibizumab vs aflibercept vs bevacizumab for the management of macular edema secondary to central retinal vein occlusion.
P. Hykin   +11 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy